L'Oreal says weight-loss drugs are reshaping beauty sales

· Health · France

L'Oreal's chief executive said the use of GLP-1 weight-loss drugs is "a very important phenomenon for us" that is impacting beauty and skin care sales, according to the BBC. The comments highlight how rapidly growing use of obesity treatments is changing consumer behaviour in cosmetics, from skincare needs to makeup preferences. Drugmakers have reported soaring demand for GLP-1 medicines, which are used for weight loss and diabetes. The beauty industry is now adjusting product lines and marketing to reflect the shift. L'Oreal is the world's largest cosmetics company.

Why it matters：The spread of GLP-1 drugs is spilling over into consumer sectors, showing how a pharmaceutical breakthrough can reshape demand well beyond healthcare.

Key points

  • L'Oreal CEO calls GLP-1 use a "very important phenomenon"
  • The drugs are impacting beauty and skin care sales
  • L'Oreal is the world's largest cosmetics company

Sources (original reporting)

More stories from this day